Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study
Authors:
- Francesco PaneniFPFrancesco Paneni
- Mario GregoriMGMario Gregori
- Giuliano TocciGTGiuliano Tocci
- Francesca PalanoFPFrancesca Palano
- Giuseppino Massimo CiavarellaGCGiuseppino Massimo Ciavarella
- Giulia PignatelliGPGiulia Pignatelli
- Andrea MarraAMAndrea Marra
- Sebastiano SciarrettaSSSebastiano Sciarretta
- Andrea FerrucciAFAndrea Ferrucci
- Massimo VolpeMVMassimo Volpe
- 6 September 2012
- journal article
- Published by Springer Nature in Hypertension Research
- Vol. 36 (1) , 36-42
Abstract
Metabolic syndrome (MetS) and type 2 diabetes (T2DM) have been associated with an impairment of left (LV) and right ventricular (RV) function as well as an increased risk of heart failure (HF). However, it remains unclear whether these clinical entities or their associations promote a similar derangement of biventricular function. Overall, 345 patients without overt cardiovascular disease consecutively underwent routine blood chemistry including high-sensitivity C reactive protein (hs-CRP) and echocardiographical examination with conventional and tissue Doppler imaging (TDI) of both ventricles. According to the ATP III criteria and fasting glucose levels, the study population was stratified into four groups: (1) healthy controls (n=120); (2) MetS without T2DM (n=84); (3) T2DM without MetS (n=49); and (4) MetS+T2DM (n=92). The Myocardial performance index (MPI) of the RV and LV was obtained with a multi-segmental approach using TDI. Patients with MetS and T2DM exhibited a similar impairment of biventricular function compared with healthy controls, whereas a further decline was observed in patients having both MetS and T2DM. In addition to MetS markers, hs-CRP exhibited the strongest association with the MPI of both ventricles. Regression analyses indicated that individual MetS markers were inferior to MetS in identifying subtle cardiac dysfunction. Independent associations of MetS and T2DM with biventricular dysfunction were comparable, and the coexistence of MetS and T2DM exhibited the highest risk for biventricular dysfunction. Our findings emphasize the importance of MetS as an equivalent of T2DM and support a synergic effect of these clinical conditions on cardiac organ damage requiring more aggressive therapeutic strategies to prevent HF.Keywords
This publication has 31 references indexed in Scilit:
- Relation between right and left ventricular function in patients undergoing chronic dialysisJournal of Cardiovascular Medicine, 2013
- Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes MellitusCirculation, 2010
- Right Ventricular Dysfunction in Patients with End-Stage Renal DiseaseAmerican Journal of Nephrology, 2010
- The impact of metabolic syndrome on left ventricular myocardial performanceDiabetes/Metabolism Research and Reviews, 2010
- Left Ventricular Diastolic Function in Type 2 Diabetes MellitusCirculation: Cardiovascular Imaging, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Platelet Activation and Cognitive Impairment in Elderly Patients with Metabolic SyndromeHigh Blood Pressure & Cardiovascular Prevention, 2008
- Utility of the Myocardial Performance Index in a Population with High Prevalences of Obesity, Diabetes, and Hypertension: The Strong Heart StudyEchocardiography, 2007
- A Doppler-derived index of combined left ventricular systolic and diastolic function is an independent predictor of cardiovascular mortality in elderly menAmerican Heart Journal, 2005
- Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and doppler echocardiographyThe American Journal of Cardiology, 1996